Henrique Previtalli-Silva

Dr. Henrique Previtalli-Silva


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in Heliyon
Verified
Journal Article
Open access
H-Henrique Previtalli -Silva
Henrique Previtalli -Silva
DHDaiana de Jesus Hardoim
Daiana de Jesus Hardoim
RBRaphael de Lucena Banaggia
Raphael de Lucena Banaggia
CMCarla Junqueira Moragas-Tellis
Carla Junqueira Moragas-Tellis
MCMaria Do Socorro dos Santos Chagas
Maria Do Socorro dos Santos Chagas
Flávia de Oliveira CardosoFlávia de Oliveira Cardoso
Flávia de Oliveira Cardoso
Euterpe oleracea Mart. is a tropical palm tree native to the Amazon region. Its fruit, commonly known as açaí, has gained widespread recognition for its therapeutic potential, driving the expansion of pharmacological studies to validate its traditional uses. Leveraging açaí seeds in research not only mitigates environmental impacts but also enables the identification of bioactive compounds with potential pharmacological applications, including drug development. Thus, the present work aims to investigate the antioxidant and anti-inflammatory activities of the hydroalcoholic extract and the ethyl acetate, hexane, dichloromethane and aqueous fractions of açaí seeds in vitro. The extract/fractions from açaí contained a significant amount of flavonoids, such as catechins and procyanidins, according to LC-MS/MS. These bioproducts showed significant antioxidant activity, with emphasis on the ethyl acetate fraction (FRAP: 4516.00 ± 58.07 Eq Trolox/g compound; DPPH: IC50 3.93 ± 0.26 μg/. mL; ABTS• +: IC50 34.65 ± 0.35 μg/mL). In addition, the compounds exhibited an anti-inflammatory action on LPS-stimulated peritoneal macrophages, with the dichloromethane fraction showing the more comprehensive inhibitory effects on NO, IL-12 and IFN-γ production, especially in the concentration of 500 μg/mL. E. oleracea seeds extract/fractions had no cytotoxic effect on peritoneal macrophages (IC50 > 500 μg/mL). These findings suggest that E. oleracea seed-derived bioproducts hold significant promise as safe and effective agents for the development of novel antioxidant and anti-inflammatory therapies targeting a variety of inflammatory pathologies.

22 June 2023 in Biology
Verified
Journal Article
Open access
PDF file
SASandra Alves de Araujo
Sandra Alves de Araujo
ALAldilene Lima
Aldilene Lima
Claudia Quintino da RochaClaudia Quintino da Rocha
Claudia Quintino da Rocha
H-Henrique Previtalli -Silva
Henrique Previtalli -Silva
DHDaiana de Jesus Hardoim
Daiana de Jesus Hardoim
ASAna Abreu- Silva
Ana Abreu- Silva
Chagas disease is a severe infectious and parasitic disease caused by the protozoan Trypanosoma cruzi and considered a public health problem. Chemotherapeutics are still the main means of control and treatment of the disease, however with some limitations. As an alternative treatment, plants have been pointed out due to their proven pharmacological properties. Many studies carried out with Terminalia catappa have shown several biological activities, but its effect against T. cruzi is still unknown. The objective of this work is to evaluate the therapeutic potential of extracts and fractions obtained from T. catappa on the parasite T. cruzi, in addition to analyzing its antioxidant activity. T. catappa ethyl acetate fraction were produced and submitted the chemical characterization by Liquid Chromatography Coupled to Mass Spectrometry (LC-MS). From all T. catappa extracts and fractions evaluated, the ethyl acetate and the aqueous fraction displayed the best antioxidant activity by the 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging method (IC50 of 7.77 ± 1.61 and 5.26 ± 1.26 µg/mL respectively), and by ferric ion reducing (FRAP) method (687.61 ± 0.26 and 1009.32 ± 0.13 µM of Trolox equivalent/mg extract, respectively). The ethyl acetate fraction showed remarkable T. cruzi inhibitory activity with IC50 of 8.86 ± 1.13, 24.91 ± 1.15 and 85.01 ± 1.21 µg/mL against epimastigotes, trypomastigotes and intracellular amastigotes, respectively, and showed no cytotoxicity for Vero cells (CC50 > 1000 µg/mL). The treatment of epimastigotes with the ethyl acetate fraction led to drastic ultrastructural changes such as the loss of cytoplasm organelles, cell disorganization, nucleus damage and the loss of integrity of the parasite. This effect could be due to secondary compounds present in this extract, such as luteolin, kaempferol, quercetin, ellagic acid and derivatives. The ethyl acetate fraction obtained from T. catappa leaves can be an effective alternative in the treatment and control of Chagas disease, and material for further investigations.

29 January 2026 in Chemistry
Verified
Journal Article
Open access
PDF file
TSThiago de Souza Dias Silva
Thiago de Souza Dias Silva
AFONSO SANTINE MAGALHAES MESQUITA VELEZAFONSO SANTINE MAGALHAES MESQUITA VELEZ
AFONSO SANTINE MAGALHAES MESQUITA VELEZ
TRTIAGO RIBEIRO RODRIGUEZ
TIAGO RIBEIRO RODRIGUEZ
JSJoão Vitor Costa Silva
João Vitor Costa Silva
H-Henrique Previtalli -Silva
Henrique Previtalli -Silva
Marco Edilson Freire De LimaMarco Edilson Freire De Lima
Marco Edilson Freire De Lima
This work reports the synthesis and characterization of a new molecular hybrid 4, created by combining 1,4-naphthoquinone with the drug zidovudine (AZT) through an azide-alkyne cycloaddition reaction catalyzed by Cu1+. In vitro studies assessed the anti-trypanosomatid activity of hybrid 4, along with its precursors and synthetic intermediates (1, 2, and 3), against Trypanosoma cruzi (T. cruzi Tulahuen C2C4 LacZ), Trypanosoma brucei (T. b. brucei 427), and Leishmania infantum, as well as cytotoxicity in RAW 264.7 macrophages and LLC-MK2 cells. The biological results confirm the molecular design, showing that the new hybrid is effective against both epimastigotes and amastigotes of T. cruzi (IC50 = 22.26 ± 5.78 μM and 143.10 ± 5.79 μM, respectively), with approximately 4.5-fold better capacity than AZT to inhibit the epimastigote form. Additionally, the hybrid was also active against bloodstream T. b. brucei (IC50 = 54.47 ± 6.70 μM), with approximately 2.2-fold better capacity than AZT to inhibit this parasite. It also shows low toxicity in RAW 264.7 macrophages (CC50 > 200 μM) and LLC-MK2 cells (CC50 > 200 μM). For example, hybrid 4 exhibited approximately a 6.6-fold higher SI than 1,4-naphthoquinone 1 against T. cruzi amastigotes. In this context, the work contributes to the broader knowledge base guiding the design of hybrid molecules for antiparasitic chemotherapy. It provides a rational foundation for preparing subsequent, more potent analogues.

2 January 2026 in Biology
Verified
Journal Article
Open access
PDF file
H-Henrique Previtalli -Silva
Henrique Previtalli -Silva
DHDaiana de Jesus Hardoim
Daiana de Jesus Hardoim
RBRaphael de Lucena Banaggia
Raphael de Lucena Banaggia
CMCarla Junqueira Moragas-Tellis
Carla Junqueira Moragas-Tellis
PSPaulo Victor Ramos de Souza
Paulo Victor Ramos de Souza
Flávia de Oliveira CardosoFlávia de Oliveira Cardoso
Flávia de Oliveira Cardoso
Chagas disease remains a major public health challenge due to the limited effectiveness and considerable side effects of existing treatments, particularly during the chronic stage. Açaí (Euterpe oleracea) seeds have gained increasing attention as a source of bioactive compounds with potential therapeutic applications. In this study, hydroalcoholic extracts and solvent fractions obtained from açaí seeds were chemically characterized by ESI/MS and HPLC–MS/MS and evaluated for their cytotoxicity and antiparasitic activity against different developmental stages of Trypanosoma cruzi (Y strain). Chemical profiling revealed a predominance of phenolic compounds, particularly catechins and procyanidins, which were identified as major constituents of the hydroalcoholic extract and the ethyl acetate fraction. Cytotoxicity assays performed on murine peritoneal macrophages demonstrated low toxicity, with CC50 values exceeding 500 µg/mL for most samples, indicating a favorable in vitro safety profile. Antiparasitic assays showed weak activity against epimastigote forms; however, significant inhibitory effects were observed against bloodstream trypomastigotes, cell culture-derived trypomastigotes, and intracellular amastigotes. Notably, the hydroalcoholic extract exhibited the highest selectivity against intracellular amastigotes, with a selectivity index greater than 10, fulfilling key criteria proposed by the Drugs for Neglected Diseases initiative (DNDi) for early-stage hit compounds. Flow cytometry analysis showed that both the hydroalcoholic extract and the ethyl acetate fraction induced parasite cell death through late apoptosis-like and necrosis. Together, these findings highlight the antiparasitic potential of E. oleracea seed extracts, particularly against clinically relevant stages of T. cruzi, and support further investigation of these bioproducts as promising candidates for the development of new therapeutic strategies for Chagas disease.

25 November 2025 in Life
Verified
Journal Article
Open access
PDF file
FSFilipe Melo da Silva
Filipe Melo da Silva
RBRaphael de Lucena Banaggia
Raphael de Lucena Banaggia
GAGiovana Marinho Arbusti
Giovana Marinho Arbusti
SFStefanny Nunes Fidelis
Stefanny Nunes Fidelis
H-Henrique Previtalli -Silva
Henrique Previtalli -Silva
KCKátia da Silva Calabrese
Kátia da Silva Calabrese
Chagas disease, caused by Trypanosoma cruzi, remains a neglected tropical disease of public health importance in Latin America, particularly in rural areas. In Floriano, Piauí, Brazil, data on infection prevalence are limited. This cross-sectional population-based study assessed the seroprevalence of T. cruzi infection and analyzed sociodemographic factors associated with seropositivity among residents of 41 rural communities in Floriano. A total of 1212 individuals aged over six years were examined, revealing a seroprevalence of 3.2% (39/1212), with positive cases detected in 17 communities. Infection was significantly associated with older age (≥60 years; p < 0.0001), low educational level (p = 0.0184), retirement status (p < 0.0001), and low income (p = 0.0505). Logistic regression confirmed age as the strongest determinant of infection (OR = 7.647; 95% CI: 3.741–18.61; p < 0.0001), while higher monthly income showed a negative association with infection (OR = 0.17; 95% CI: 0.01–0.82; p = 0.086), indicating a trend toward significance. These findings highlight the persistence of T. cruzi infection in rural Floriano, predominantly among elderly individuals living in poverty. The identification of previously undiagnosed chronic cases reinforces the urgent need for targeted epidemiological surveillance, early diagnosis, and community-based health education to strengthen local control and prevention strategies.